Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)

Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients

NCT00949741 ·Status: COMPLETED

Immunological Senescence Phenotype as a Resistance Profile to Pembrolizumab in Patients With Relapsed/Refractory Hodgkin's Lymphoma

NCT06733987 ·Status: RECRUITING

An Italian Multicentric Retrospective Observational Study to Assess Effectiveness and Safety of the Combination of Tafasitamab and Lenalidomide in Diffuse Large B-cell Lymphoma Patients Treated Under Named Patient Program

NCT06782789 ·Status: RECRUITING

Indolent Non Follicular Lymphomas Prognostic Project

NCT02904577 ·Status: COMPLETED

Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment

NCT02341781 ·Status: COMPLETED

Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen

NCT01478269 ·Status: COMPLETED

Fase II Study With BRB for Non-Hodgkin Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia's

NCT02371148 ·Status: COMPLETED ·Phase: PHASE2

Primary Mediastinal Large B-cell Lymphoma (PMBCL): Multicenter Retrospective Study

NCT05162170 ·Status: COMPLETED

Multicenter Retrospective Observational Study of Relapsed Diffuse Large B-Cell Lymphoma Presenting as Indolent Lymphoma

NCT06822829 ·Status: RECRUITING

Immunochemotherapy With Rituximab-Bendamustine-Cytarabine (R-BAC) for Patients With Mantle Cell Lymphoma

NCT00992134 ·Status: COMPLETED ·Phase: PHASE2

Molecular Characterization and Outcomes of Aggressive B-Cell Lymphomas.

NCT07181785 ·Status: COMPLETED

Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma

NCT05700149 ·Status: RECRUITING

Primary Mediastinal Large B-cell Lymphoma With CNS Involvement

NCT06024694 ·Status: ACTIVE_NOT_RECRUITING

A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice

NCT06008691 ·Status: RECRUITING

Study of Epigenetic and Inflammatory Markers of Accelerated Biological Ageing in the Follow up of Patients With Hodgkin's Lymphoma

NCT06761274 ·Status: RECRUITING ·Phase: NA

An Italian Experience on Grade 3b Follicular Lymphoma

NCT02927717 ·Status: UNKNOWN

Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma

NCT00509379 ·Status: COMPLETED ·Phase: PHASE2

A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell Lymphoma

NCT05564052 ·Status: COMPLETED ·Phase: PHASE2

Mantel Cell Lymphoma Efficacy of Rituximab Maintenance

NCT00921414 ·Status: COMPLETED ·Phase: PHASE3

Phase II of Efficacy and Toxicity of Maintenance Sub. Rituximab After Induction in Relapsed MCL and Non-eligible HSCT

NCT02267915 ·Status: UNKNOWN ·Phase: PHASE2

REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs

NCT05223413 ·Status: RECRUITING ·Phase: NA

Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas

NCT06585124 ·Status: RECRUITING

Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas

NCT06806488 ·Status: RECRUITING

Mediastinal Recurrence of Lympho-proliferative Disorders: a Biopsy is Needed

NCT06714045 ·Status: COMPLETED

Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America

NCT02559583 ·Status: COMPLETED